Be the first to like this
The Knowledge Group has developed a panel of key thought Leaders and practitioners to help companies understand the Hart-Scott-Rodino (HSR) rules for patent acquisitions, including the new rules of the Federal Trade Commission (FTC) for exclusive pharmaceutical patent licenses. The program will cover the most significant topics involved along with a Q&A panel to whom the attendees’ questions will be addressed.
Key Topics includes:
The HSR Act: An Overview
The “Size of Transaction” Test
The “Size of Parties” Test
Patents as “Assets” Whose Acquisition May Be Reportable
Patent Acquisitions in the Pharmaceutical Industry: What Is New and What Is Not under the Amended Rules?
Impact and Key Risks
Up-to-Minute Regulatory Updates
To view the webcast go to this link: http://youtu.be/3AhqADcjzp4
To learn more about the webcast please visit our website: http://theknowledgegroup.org/